GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract manufacturing organization, expands its capabilities in syringe filling at its ...

Viscosity-dependent behaviors such as drips, stringiness, and air entrapment can destabilize fill accuracy and visual inspection, necessitating tailored methodologies and tighter process controls.

Grand Rapids, Michigan, April 14, 2026 (GLOBE NEWSWIRE)-- Grand River Aseptic Manufacturing (“GRAM”), an Arlington Capital Partners portfolio company, is a leading provider of sterile fill-finish ...

Dublin, March 11, 2026 (GLOBE NEWSWIRE)-- The "Aseptic Fill Finish Manufacturing Market (2nd Edition) by Type of Molecule, Type of Biologic Manufactured, Type of Packaging Container, Scale of ...

FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 ...

Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile ...

Baxter Biopharma Solutions, the CDMO arm of healthcare giant Baxter, will shell out $100 million to expand its fill-finish manufacturing facility in Germany. The company plans to grow the footprint of ...

Becton, Dickinson and Company BDX, also popularly known as BD, announced its decision to invest $1.2 billion to expand and upgrade manufacturing capacity as well as technology for pre-fillable ...

The company is enhancing its U.S. sterile fill-finish contract manufacturing services to meet growing industry demand for prefilled syringes and cartridges that support patient-friendly administration ...